Zepp Health Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Zepp Health wird ein Gewinn- und Umsatzwachstum von 131.4% bzw. 13% pro Jahr prognostiziert, während der Gewinn pro Aktie um 152.8% pro Jahr wachsen soll.

Wichtige Informationen

131.4%

Wachstumsrate der Gewinne

152.8%

EPS-Wachstumsrate

Electronic Gewinnwachstum	14.7%
Wachstumsrate der Einnahmen	13.0%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	24 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Apr 17

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Dec 23

Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?

Feb 23

Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh

Jan 06

When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?

Dec 15

Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist

Oct 28

Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch

Oct 15

Zepp: A Solid International Diversification Play

Oct 03

Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?

Sep 13

Zepp Health: Taking Over The Smart Health Wearables Market

Jul 14

We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt

Jul 07

Returns On Capital Are Showing Encouraging Signs At Zepp Health (NYSE:ZEPP)

May 31

Zepp Health Boosts R&D To Minimize Reliance On Xiaomi, Remains A Good Bet

May 08

Zepp Or Huami? Wearable Device Maker In China-U.S. Identity Crisis

Apr 26

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Apr 08

We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt

Mar 18

What We Make Of Huami's (NYSE:HMI) Returns On Capital

Feb 19

Gewinn- und Umsatzwachstumsprognosen

NYSE:ZEPP - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	2,657	13	65	N/A	2
12/31/2024	2,226	-53	119	N/A	2
3/31/2024	2,137	-181	N/A	N/A	N/A
12/31/2023	2,495	-212	287	299	N/A
9/30/2023	2,967	-279	N/A	N/A	N/A
6/30/2023	3,571	-299	N/A	N/A	N/A
3/31/2023	4,031	-336	N/A	N/A	N/A
12/31/2022	4,143	-288	-798	-788	N/A
9/30/2022	4,733	-176	N/A	N/A	N/A
6/30/2022	5,133	-110	N/A	N/A	N/A
3/31/2022	5,860	90	N/A	N/A	N/A
12/31/2021	6,250	138	-286	-232	N/A
9/30/2021	6,561	217	N/A	N/A	N/A
6/30/2021	7,190	248	N/A	N/A	N/A
3/31/2021	6,492	169	N/A	N/A	N/A
12/31/2020	6,433	229	73	157	N/A
9/30/2020	6,572	320	N/A	N/A	N/A
6/30/2020	6,200	442	N/A	N/A	N/A
3/31/2020	6,101	518	N/A	N/A	N/A
12/31/2019	5,812	573	382	428	N/A
9/30/2019	4,925	480	N/A	N/A	N/A
6/30/2019	4,138	391	N/A	N/A	N/A
3/31/2019	3,859	387	N/A	N/A	N/A
12/31/2018	3,645	113	638	708	N/A
9/30/2018	3,173	25	N/A	N/A	N/A
6/30/2018	2,573	-69	N/A	N/A	N/A
3/31/2018	2,304	-139	N/A	N/A	N/A
12/31/2017	2,049	46	N/A	238	N/A
9/30/2017	1,909	54	N/A	294	N/A
12/31/2016	1,556	-12	N/A	17	N/A
12/31/2015	896	-61	N/A	-7	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: ZEPP wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: ZEPPDie Einnahmen des Unternehmens (13% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.5% pro Jahr).

Hohe Wachstumseinnahmen: ZEPPDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ZEPP in 3 Jahren voraussichtlich hoch sein wird

Zepp Health Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 97%

Price target increased by 29% to US$3.99

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2023

Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2023

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2023

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2022

Recent updates

New major risk - Revenue and earnings growth

Zepp Health Corporation to Report Q1, 2024 Results on May 20, 2024

Zepp Health Announces US Launch Date for Amazfit Helio Ring

Full year 2023 earnings: EPS and revenues miss analyst expectations

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Consensus EPS estimates fall by 97%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Zepp Health Corporation to Report Q4, 2023 Results on Mar 18, 2024

Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

New minor risk - Share price stability

Price target increased by 29% to US$3.99

Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales

Third quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.28 loss in 3Q 2022)

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2023

Zepp Health Corporation to Report Q3, 2023 Results on Nov 20, 2023

Zepp Health Corporation Launches Amazfit Balance with AI-Empowered Features for the Ultimate in Balanced Living

Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2023

Second quarter 2023 earnings released: CN¥1.15 loss per share (vs CN¥1.74 loss in 2Q 2022)

Zepp Health Corporation to Report Q2, 2023 Results on Aug 21, 2023

Zepp Health Corporation Announces Amazfit Makes the New Amazfit Bip 5 Globally Available

Can Zepp Health Find Its Way Back Up?

Amazfit Launches New Amazfit Cheetah Series

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2023

First quarter 2023 earnings released: CN¥2.23 loss per share (vs CN¥1.42 loss in 1Q 2022)

Zepp Health Corporation to Report Q1, 2023 Results on May 23, 2023

Full year 2022 earnings released: CN¥4.68 loss per share (vs CN¥2.19 profit in FY 2021)

Third quarter 2022 earnings released: CN¥0.28 loss per share (vs CN¥0.78 profit in 3Q 2021)

Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2022

Amazfit Launches Challenge on Adidas Apps Following Partnership Announcement

Price target decreased to US$2.75

Less than half of directors are independent

Zepp Health Corporation to Report Q3, 2022 Results on Nov 21, 2022

Amazfit Unveils Next-Level Sports and Lifestyle Experiences with the New Amazfit GTR 4 and GTS 4 Smartwatches

Second quarter 2022 earnings released: CN¥1.74 loss per share (vs CN¥1.47 profit in 2Q 2021)

Zepp Health Corporation Provides Earnings Guidance for the Third Quarter of 2022

Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M

Investor sentiment improved over the past week

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Zepp Health Corporation to Report Q2, 2022 Results on Aug 25, 2022

Amazfit Launches its Latest Firmware Update for OTS Rugged Outdoor GPS Smartwatch, the Amazfit T-Rex 2

Amazfit Unveils Newest Compact and Power-Packed Smartwatch, the Amazfit GTS 4 Mini

Amazfit Sends the Super-Tough T-Rex 2 Smartwatch on A Space Ride

Amazfit Introduces Best-Value Essential Smartwatch Additions, the Amazfit Bip 3 and Bip 3 Pro

Zepp Health Corporation, Annual General Meeting, Jul 05, 2022

Zepp: Speculative, But With Potentially Great Rewards

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022

Price target decreased to US$5.53

Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022

Zepp Health Corporation to Report Q1, 2022 Results on May 24, 2022

Full year 2021 earnings released: EPS: CN¥2.19 (vs CN¥3.68 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings: Revenues miss analyst expectations

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Investor sentiment deteriorated over the past week

Zepp Health Corporation to Report Q4, 2021 Results on Mar 17, 2022

Investor sentiment deteriorated over the past week

Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?

Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh

Zepp Health Corp. Provides Guidance for the Fourth Quarter of 2021

Investor sentiment deteriorated over the past week

When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released

Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist

Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch

Price target decreased to US$13.00

Zepp: A Solid International Diversification Play

Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?